ICON opened a new office in Paris, France, its fourth facility in Europe and tenth worldwide. The progress achieved continues to validate our strategy of providing high quality services to the biopharmaceutical industry on a global basis. During the quarter we opened our new office in Paris, France, a step which we believe will help us continue to expand our business, and initiated the extension of our headquarters in Dublin, and the relocation of our headquarters in the US, both of which are needed to accommodate our rapidly increasing work force.
ICON provides contract clinical research services to the pharmaceutical industry world-wide.
It currently has ten offices in seven countries and over 525 employees world-wide. These statements involve risks and uncertainties that could cause actual results to differ materially including, without limitation, actual operating performance, the ability to maintain large client contracts or enter into new contracts, the ability to manage the opening of new offices, and the ability to maintain client relationships.